American Journal of Cardiology
Volume 103, Issue 3 , Pages 393-394 , 1 February 2009

Once-a-Week Rosuvastatin (2.5 to 20 mg) in Patients With a Previous Statin Intolerance

Received 5 August 2008 ,Revised 25 September 2008 ,Accepted 25 September 2008.

References 

  1. Backes JM, Carmelo VV, Gibson CA, Ruisinger JF, Howard PA, Thompson PD, et al. Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance. Ann Pharmacother. 2008;42:341–346
  2. Mackie BD, Satija S, Nell C, Miller J, Sperling LS. Monday, Wednesday, and Friday dosing of rosuvastatin in patients previously intolerant to statin therapy. Am J Cardiol. 2007;99:291
  3. Gadarla M, Kearns AK, Thompson PD. Efficacy of rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins. Am J Cardiol. 2008;101:1747–1748
  4. Executive summary of the third report of the National Cholesterol Education Panel (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
  5. Backes JM, Moriarty PM, Ruisinger JF, Gibson CA. Effects of once weekly rosuvastatin among patients with a prior statin intolerance. Am J Cardiol. 2007;100:554–555
  6. Olsson AG, Pears J, McKellar J, Mizan J, Raza A. Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia. Am J Cardiol. 2001;88:504–508
  7. Lopez LM. Rosuvastatin: A high-potency HMG-CoA-reductase inhibitor. J Am Pharm Assoc. 2005;45:503–513
  8. Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial). Am J Cardiol. 2003;92:152–160

PII: S0002-9149(08)01713-X

doi: 10.1016/j.amjcard.2008.09.095

American Journal of Cardiology
Volume 103, Issue 3 , Pages 393-394 , 1 February 2009

Article Tools

* Image Usage & Resolution